EP2958550
ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.2.2014EP published:
17.8.2022EP application number:
14710642.1
EPO information:
European Patent Register
Max expiry date:
20.2.2034
Title in English:
ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUGLanguage of the patent:
English
Timeline
Today
21.2.2014EP application
17.8.2022EP Publication
Owner
Name:
Sun Pharmaceutical Industries LimitedAddress:
SPARC, TANDALJA, Vadodara, Gujarat-390012, IN
Inventor
Name:
DECAUDIN, CélineAddress:
4056 Basel, CH
Name:
ROGUE, VincentAddress:
4056 Basel, CH
Priority
Number:
201361768803 PDate:
25.2.2013Country:
US
Classification
Categories:
A61K 9/10, A61K 47/14, A61K 31/5377, A61P 35/00